Page last updated: 2024-11-05

tranexamic acid and Stevens-Johnson Syndrome

tranexamic acid has been researched along with Stevens-Johnson Syndrome in 2 studies

Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.

Stevens-Johnson Syndrome: Rare cutaneous eruption characterized by extensive KERATINOCYTE apoptosis resulting in skin detachment with mucosal involvement. It is often provoked by the use of drugs (e.g., antibiotics and anticonvulsants) or associated with PNEUMONIA, MYCOPLASMA. It is considered a continuum of Toxic Epidermal Necrolysis.

Research Excerpts

ExcerptRelevanceReference
"To report a case of toxic epidermal necrolysis (TEN) induced by orally administered tranexamic acid in a patient with liver cirrhosis and acute rectal bleeding."3.79Tranexamic acid-induced toxic epidermal necrolysis. ( Aguado Gil, L; Idoate Gastearena, MA; Marques Martin, L; Pretel Irazabal, M, 2013)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Adams, L1
Creamer, D1
Pretel Irazabal, M1
Marques Martin, L1
Aguado Gil, L1
Idoate Gastearena, MA1

Other Studies

2 other studies available for tranexamic acid and Stevens-Johnson Syndrome

ArticleYear
Controlling oral hemorrhages in Steven-Johnson syndrome/toxic epidermal necrolysis.
    Journal of the American Academy of Dermatology, 2020, Volume: 82, Issue:1

    Topics: Administration, Topical; Antifibrinolytic Agents; Hospitals, University; Humans; Mouth Mucosa; Oral

2020
Tranexamic acid-induced toxic epidermal necrolysis.
    The Annals of pharmacotherapy, 2013, Volume: 47, Issue:3

    Topics: Aged; Antifibrinolytic Agents; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Male; Stevens-J

2013